Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aimmune Therap (AIMT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,647,929
  • Shares Outstanding, K 51,530
  • Annual Sales, $ 0 K
  • Annual Income, $ -80,820 K
  • 36-Month Beta -0.82
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 9.21

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.40 +7.63%
on 02/23/18
42.00 -22.10%
on 02/20/18
-5.33 (-14.01%)
since 01/23/18
3-Month
30.40 +7.63%
on 02/23/18
42.00 -22.10%
on 02/20/18
-3.02 (-8.45%)
since 11/22/17
52-Week
15.97 +104.88%
on 05/31/17
42.00 -22.10%
on 02/20/18
+13.15 (+67.19%)
since 02/23/17

Most Recent Stories

More News
Aimmune Therapeutics Announces Pricing of Public Offering of Common Stock

Aimmune Therapeutics, Inc. (NASDAQ:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced the pricing of an underwritten...

AIMT : 32.72 (+2.31%)
Aimmune Therapeutics Announces Proposed Public Offering of Common Stock

Aimmune Therapeutics, Inc. (NASDAQ:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that it has commenced an underwritten...

AIMT : 32.72 (+2.31%)
Look for Shares of Aimmune Therapeu to Potentially Rebound after Yesterday's 6.24% Sell Off

Aimmune Therapeu (NASDAQ:AIMT) traded in a range yesterday that spanned from a low of $34.05 to a high of $42.00. Yesterday, the shares fell 6.2%, which took the trading range below the 3-day low of...

AIMT : 32.72 (+2.31%)
Aimmune Therapeutics' Pivotal Phase 3 PALISADE Trial of AR101 Meets Primary Endpoint in Patients With Peanut Allergy

--The lower-bound of the 95% confidence interval (CI) of the difference between treatment arms at the primary endpoint was 53.0%, greatly exceeding the pre-specified threshold of 15% (p

AIMT : 32.72 (+2.31%)
Aimmune Therapeutics Expands Scientific Advisory Board With Appointments of George du Toit, M.B., B.Ch., and Wayne Shreffler, M.D., Ph.D.

---- Prof. du Toit Is Lead Author of Landmark LEAP and LEAP-On Studies on Prevention of Peanut Allergy in Young Children --

AIMT : 32.72 (+2.31%)
Aimmune Therapeutics Announces Presentations at 2018 AAAAI-WAO Joint Congress

Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that it will present data during...

AIMT : 32.72 (+2.31%)
63.9% Return Seen to Date on SmarTrend Aimmune Therapeu Call (AIMT)

SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on September 7th, 2017 at $22.31. In approximately 5 months, Aimmune Therapeu has returned 63.87% as of today's recent price of $36.56....

AIMT : 32.72 (+2.31%)
Interesting AIMT Put And Call Options For April 20th

Investors in Aimmune Therapeutics Inc saw new options begin trading today, for the April 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the...

AIMT : 32.72 (+2.31%)
Report: Exploring Fundamental Drivers Behind Stericycle, Hemisphere Media Group, Expedia, Olin, Aimmune Therapeutics, and Waste Management -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Stericycle, Inc. (NASDAQ:SRCL),...

OLN : 33.20 (+0.15%)
AIMT : 32.72 (+2.31%)
HMTV : 11.25 (+1.35%)
WM : 85.49 (+1.17%)
EXPE : 106.38 (+1.77%)
SRCL : 60.05 (-0.96%)
Aimmune Therapeu Rises 3.88% on Heavy Volume: Watch For Potential Pullback

Aimmune Therapeu (NASDAQ:AIMT) traded in a range yesterday that spanned from a low of $36.91 to a high of $38.92. Yesterday, the shares gained 3.9%, which took the trading range above the 3-day high...

AIMT : 32.72 (+2.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Aimmune Therapeutics, Inc. is a biopharmaceutical company which is engaged in the development of desensitization treatments for peanut and other food allergies. The Company's characterized oral desensitization immunotherapy includes AR101, a product for the treatment of peanut allergy in children and...

See More

Key Turning Points

2nd Resistance Point 34.41
1st Resistance Point 33.57
Last Price 32.72
1st Support Level 31.14
2nd Support Level 29.55

See More

52-Week High 42.00
Last Price 32.72
Fibonacci 61.8% 32.06
Fibonacci 50% 28.99
Fibonacci 38.2% 25.91
52-Week Low 15.97

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.